[Individual characteristics of the brain energy metabolism during local ischemia obtained by nuclear magnetic resonance in vivo].

N. Semenova,A. Topchian,R. S. Mirzoian,A. Konradov,M. G. Balasanian

Abstract:

What problem does this paper attempt to address?

Abstract 11630: Comparing Outcomes Between Robotic Assisted versus Manual Percutaneous Coronary Intervention - A Meta-Analysis of 2,203 Patients

Rahul Gupta,aaqib malik,Surya K Aedma,Wilbert S Aronow,Apurva Vyas,Sanjay Mehta,William G Combs,Nainesh Patel

DOI: https://doi.org/10.1161/circ.144.suppl_1.11630

IF: 37.8

2021-11-16

Circulation

Abstract:Introduction: Robotics in percutaneous coronary intervention (R-PCI) has been one such area of advancement where potential benefits may include reduction in radiation exposure, improved outcomes and reduced rate of adverse events. Robotic assistance may offer many potential benefits to both the operator and the patient. Limited data exist about the benefits of R-PCI vs. conventional manual PCI (M-PCI). Hypothesis: The aim for our meta-analysis is to evaluate the procedural measures and clinical outcomes between R-PCI and M-PCI. Methods: A comprehensive literature search was performed in PubMed, Embase, and Cochrane to identify relevant clinical studies. Summary effects were calculated using a DerSimonian and Laird random effects model as odds ratio with 95% confidence intervals for all the clinical endpoints. All studies adhering to the inclusion criteria of direct comparisons between R-PCI and M-PCI were evaluated. Results: Seven studies with a total of 2,230 patients were identified. There was significant decrease in the chest-level operator radiation exposure (OR= -442.32; 95% CI = -675.88 to -208.76), fluoroscopy time (OR = -1.46; 95% CI -2.92 to 0.00) and amount of contrast used (OR= -18.28; 95% CI -24.16 to -12.41) in the robotic group as compared to the manual group. PCI time (OR = 2.41; 95% CI -3.95 to 8.76) and procedural success rate (OR 1.26; CI 0.19-8.22) was not statistically different between the two groups. In terms of clinical outcomes, there was no difference between R-PCI and M-PCI in terms of major adverse cardiac events (OR 0.90; CI 0.45-1.79), all-cause mortality (OR 0.95; CI 0.21-4.30), and myocardial infarction (OR 0.88; CI 0.41-1.89). Conclusions: Robotic PCI is associated with reduced operator radiation exposure, fluoroscopy time and amount of contrast used. While there is a significant reduction in the procedural characteristics with robotic PCI, the clinical outcomes are not different compared to manual PCI. Use of robotics in PCI appears to be safe and potentially favorable to the patients, in addition to its benefits of improved ergonomics. More randomized studies looking at the use of R-PCI, especially in complex lesions, are needed before consideration for widespread implementation.

cardiac & cardiovascular systems,peripheral vascular disease
Local anaesthetic effects on trophoblast membrane fluidity.

R. Staffolani,N. Cester,R. Magnanelli,M. Familiari,P. Pigini,C. Tonnini,G. Lenaz,L. Mazzanti

1993-03-01

Abstract:Previous studies showed that anaesthesia with the barbiturate Thiopental induces an increase in membrane fluidity and a decrease in acetylcholinesterase activity in syncytiotrophoblast plasma membranes (SPM) obtained from placentas after Cesarean section. The aim of the present work was to compare the effect of a local anaesthetic (bupivacaine hydrochloride, trade name Marcaine) on SPM in vivo and to establish whether the anaesthetic is still present in the membrane after tissue preparation. The acetylcholinesterase activity was lower in Marcaine-anaesthetized SPM (27 +/- 3 against 39 +/- 6 in the control). The Marcaine action on the SPM can be ascribed to a competitive inhibition, similar to that reported for Thiopental. Fluorescence studies of the order parameter P showed it to be higher in SPM obtained from control (0.253 +/- 0.012) than in SPM obtained from Marcaine-exposed membranes (0.240 +/- 0.015). The local anaesthetic is still present in the SPM after their preparation (20.1 ng per mg membrane protein). It appears that the local anaesthetic exhibits an effect similar to that of the general anaesthetic, apparently due to binding to the membrane.
A Systematic Review of R-PCI

Max Wagener,Yoshinobu Onuma,Ruth Sharif,Eileen Coen,William Wijns,Faisal Sharif

DOI: https://doi.org/10.3390/jcm13185537

IF: 3.9

2024-09-20

Journal of Clinical Medicine

Abstract:Background: Ischaemic heart disease is one of the major drivers of cardiovascular death in Europe. Since the first percutaneous coronary intervention (PCI) in 1977, developments and innovations in cardiology have made PCI the treatment of choice for stenotic coronary artery disease. To address the occupational hazards related to chronic exposure to radiation and wear and tear from heavy lead-based radioprotective aprons, the concept of robotically assisted PCI (R-PCI) was introduced in 2005. Aim: To explore the features and limitations of R-PCI, we first discuss the concept and evolution of R-PCI platforms and then systematically review the available clinical data. Methods: A systematic review has been performed across the Pubmed, Embase and Cochrane databases in order to assess the efficacy and safety of R-PCI. Secondary endpoints, such as operator and patient exposure to radiation, contrast volume used and procedural time, were assessed when available. Results: In selected patients, R-PCI provides high technical and clinical success rates, ranging from 81 to 98.8% and from 93.3 to 100%, respectively. In-hospital and 1-year MACE rates ranged from 0 to 10.4% and 4.8 to 10.5%, respectively. R-PCI is able to significantly reduce the operator's exposure to radiation. Further research analysing the patient's and cath lab staff's exposure to radiation is needed. Therapy escalation with R-PCI seems to be limited to complex lesions. R-PCI procedures add approximately 10 min to the procedural time. Conclusions: The efficacy and safety of R-PCI have been proven, and R-PCI is able to significantly reduce occupational hazards for the first operator. The lack of adoption in the community of interventional cardiologists may be explained by the fact that current generations of R-PCI platforms are limited by their incompatibility with advanced interventional devices and techniques needed for escalation in complex interventions.

medicine, general & internal
Twelve-month outcome of robotic assisted PCI

J Rilinger,M Jeuck,T Maulhardt,T Hartikainen,D Westermann,C Von Zur Muehlen

DOI: https://doi.org/10.1093/eurheartj/ehae666.1448

IF: 39.3

2024-10-28

European Heart Journal

Abstract:Background Robotics in interventional cardiology (R-PCI) is a technique with high potential for optimising the outcome of patients with coronary heart disease. In order to compare R-PCI with conventional, manual PCI (M-PCI), it is necessary to analyse both the index procedure during the initial hospital stay and, in particular, the long-term outcome. Methods We report twelve-month follow up data of our prospective FRiK registry, started in mid 2021. This registry focuses on success rates and safety, radiation dose of patients and personnel as well as long-term outcome (after 6 and 12 months). Moreover, R-PCI is compared with M-PCI in these categories. Results 73 patients received R-PCI. PCI success rate was 100%, with 17.8% requiring manual assistance. Rate of complications (MACE - major adverse cardiovascular events) was 0%. Compared with 152 M-PCI patients, treated by the same interventionalists, there was a higher median procedural time (diagnostic and intervention) 102.5 (82.8-123.5) min vs. 73 (51-101.5) (p<0.001) and fluoroscopy time 18.3 (14.4-26.6) min vs. 16.2 (9.8-23.4) min (p=0.037) in R-PCI patients. However, there was no significant difference between the dose-area product 4062 (2337-5990) cGycm2 vs. 3747 (2238-5904) cGycm2 (p=0.878) and contrast volume use 180 (140-250) ml vs. 180 (135-235) ml (p=0.370, figure 1). Twelve months after the intervention, all patients in both groups were alive. R-PCI and M-PCI had comparable rates of rehospitalisation (11.4% vs. 8.1%, p=0.903) and unscheduled PCI (4.3% vs. 2.7%, p=0.932, figure 2). Target vessel failure occurred in one vs. two patients in the R-PCI and M-PCI group, respectively (1.4% vs. 1.3%, p=0.932). Conclusion R-PCI showed a high success rate, low rates for need of manual assistance, and a very high safety profile without any complications. Also at 12-month follow-up, R-PCI was comparable to the M-PCI in all categories.Comparison of procedural characteristicsComparison of twelve-month outcome

cardiac & cardiovascular systems
Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience

James Leung,John French,James Xu,Hashim Kachwalla,Krishna Kaddapu,Tamer Badie,Christian Mussap,Rohan Rajaratnam,Dominic Leung,Sidney Lo,Craig Juergens

DOI: https://doi.org/10.1016/j.hlc.2024.01.019

2024-02-01

Abstract:BACKGROUND & AIM: <AbstractText Label="BACKGROUND & AIM" NlmCategory="OBJECTIVE">Robotic-assisted percutaneous coronary intervention (R-PCI) has been increasingly performed overseas. Initial observations have demonstrated its clinical efficacy and safety with additional potential benefits of more accurate lesion assessment and stent deployment, with reduced radiation exposure to operators and patients. However, data from randomised controlled trials or clinical experience from Australia are lacking.</AbstractText>METHODS: <AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-centre experience of all patients undergoing R-PCI as part of the run-in phase for an upcoming randomised clinical trial (ACTRN12623000480684). All R-PCI procedures were performed using the CorPath GRX robot (Corindus Vascular Robotics, Waltham, Massachusetts, USA). Key inclusion criteria included patients with obstructive coronary disease requiring percutaneous coronary intervention. Major exclusion criteria included ST-elevation myocardial infarction, cardiogenic shock or lesions deemed unsuitable for R-PCI by the operator. Clinical success was defined as residual stenosis <30% without in-hospital major adverse cardiovascular events (MACE). Technical success was defined as the completion of the R-PCI procedure without unplanned manual conversion. Procedural characteristics were compared between early (cases 1-3) and later (cases 4-21) cases.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-one (21) patients with a total of 24 lesions were analysed. The mean age of patients was 66.5 years, and 66% of cases were male. Radial access was used in 18 cases (86%). Most lesions were American Heart Association/American College of Cardiology class B2/C (66%). Clinical success was achieved in 100% with manual conversion required in four cases (19%). No procedural complications or in-hospital MACE occurred. Compared to the early cases, later cases had a statistically significantly shorter fluoroscopy time (44.0mins vs 25.2mins, p<0.007), dose area product (967.3 dGy.cm<sup>2</sup> vs 361.0dGy.cm<sup>2</sup>, p=0.01) and air kerma (2484.3mGy vs 797.4mGy, p=0.009) with no difference in contrast usage (136.7mL vs 131.4mL, p=0.88).</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We present the first clinical experience of R-PCI in Australia using the Corindus CorPath GRX robot. We achieved clinical success in all patients and technical success in the majority of cases with no procedural complications or in-hospital MACE. With increasing operator and staff experience, cases required shorter fluoroscopy time and less radiation exposure but similar contrast usage.</AbstractText>

cardiac & cardiovascular systems
Comparison of Robotic Percutaneous Coronary Intervention With Traditional Percutaneous Coronary Intervention

Tejas M. Patel,Sanjay C. Shah,Yash Y. Soni,Rajni C. Radadiya,Gaurav A. Patel,Pradyot O. Tiwari,Samir B. Pancholy

DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.119.008888

2020-05-15

Abstract:Robotic percutaneous coronary intervention (R-PCI) has been shown to benefit the operator but has not shown any significant benefit to the patient. We sought to compare a large cohort of R-PCI to traditional percutaneous coronary intervention (PCI) procedures performed at a tertiary care center in the same time frame. A total of 996 consecutive patients referred for PCI between December 2017 and March 2019 were studied, of which 310 (31.1%) patients were selected to undergo R-PCI and 686 (68.9%) patients underwent traditional PCI. The coprimary study outcome measures were air kerma, dose-area product, fluoroscopy time, volume of contrast, and total procedural time. Caliper propensity-matching technique was used (caliper, 0.05) to match each R-PCI patient to the nearest traditional PCI patient without replacement. Air kerma (mGy; median [interquartile range]; P ; 884 [537–1398] versus 1110 [699–1498]; P =0.002) and dose-area product (cGycm 2 ; 4734 [2695–7746] versus 5746 [3751–7833]; P =0.003) were significantly lower in the R-PCI group. There was no difference in fluoroscopy time (minutes; 5.51 [3.53–8.31] versus 5.48 [3.31–9.37]; P =0.936) and contrast volume (mL; 130 [103–170] versus 140 [100–180]; P =0.905). Total procedural time (minutes) was significantly higher in the R-PCI group (27 [21–40] versus 37 [27–50]; P <0.0005). R-PCI is associated with a significant decrease in radiation exposure to the patient with no increase in fluoroscopy time, as well as contrast utilization, and a minor increase in procedure duration compared with traditional PCI. Download figure Download PowerPoint
Multiple endokrine Neoplasie assoziiert mit multiplen Lipomen

Marion A. Hofmann,T. Schilling,P. Heilmann,O. Haisken,C. Wüster,M. L. Brandi,R. Ziegler,P. Nawroth

DOI: https://doi.org/10.1007/BF03042664

1998-09-01

Medizinische Klinik

Abstract:
Robotics in percutaneous cardiovascular interventions

Ali Pourdjabbar,Lawrence Ang,Omid Behnamfar,Mitul P. Patel,Ryan R. Reeves,Paul T Campbell,Ryan D Madder,Ehtisham Mahmud

DOI: https://doi.org/10.1080/14779072.2017.1377071

2017-09-15

Expert Review of Cardiovascular Therapy

Abstract:INTRODUCTION: The fundamental technique of performing percutaneous cardiovascular (CV) interventions has remained unchanged and requires operators to wear heavy lead aprons to minimize exposure to ionizing radiation. Robotic technology is now being utilized in interventional cardiology partially as a direct result of the increasing appreciation of the long-term occupational hazards of the field. This review was undertaken to report the clinical outcomes of percutaneous robotic coronary and peripheral vascular interventions. Areas covered: A systematic literature review of percutaneous robotic CV interventions was undertaken. The safety and feasibility of percutaneous robotically-assisted CV interventions has been validated in simple to complex coronary disease, and iliofemoral disease. Studies have shown that robotically-assisted PCI significantly reduces operator exposure to harmful ionizing radiation without compromising procedural success or clinical efficacy. In addition to the operator benefits, robotically-assisted intervention has the potential for patient advantages by allowing more accurate lesion length measurement, precise stent placement and lower patient radiation exposure. However, further investigation is required to fully elucidate these potential benefits. Expert commentary: Incremental improvement in robotic technology and telecommunications would enable treatment of an even broader patient population, and potentially provide remote robotic PCI.
Contribution and advances of robotics in percutaneous oncological interventional radiology

Sylvain Bodard,Sylvain Guinebert,Platon M. Dimopoulos,Vania Tacher,Francois H. Cornelis

DOI: https://doi.org/10.1016/j.bulcan.2024.06.004

IF: 1.318

2024-08-30

Bulletin du Cancer

Abstract:Summary The advent of robotic systems in interventional radiology marks a significant evolution in minimally invasive medical procedures, offering enhanced precision, safety, and efficiency. This review comprehensively analyzes the current state and applications of robotic system usage in interventional radiology, which can be particularly helpful for complex procedures and in challenging anatomical regions. Robotic systems can improve the accuracy of interventions like microwave ablation, radiofrequency ablation, and irreversible electroporation. Indeed, studies have shown a notable decrease of an average 30% in the mean deviation of probes, and a 40% lesser need for adjustments during interventions carried out with robotic assistance. Moreover, this review highlights a 35% reduction in radiation dose and a stable-to-30% reduction in operating time associated with robot-assisted procedures compared to manual methods. Additionally, the potential of robotic systems to standardize procedures and minimize complications is discussed, along with the challenges they pose, such as setup duration, organ movement, and a lack of tactile feedback. Despite these advancements, the field still grapples with a dearth of randomized controlled trials, which underscores the need for more robust evidence to validate the efficacy and safety of robotic system usage in interventional radiology.

oncology
OFFPRINTED FROM Moral Particularism

L. Blum

Abstract:
Latest Developments in Robotic Percutaneous Coronary Interventions

Arif A Khokhar,Andrea Marrone,Konstantinos Bermpeis,Eric Wyffels,Maria Tamargo,Francisco Fernandez-Avilez,Rossella Ruggiero,Adriana Złahoda-Huzior,Francesco Giannini,Aleksander Zelias,Ryan Madder,Dariusz Dudek,Rafael Beyar

DOI: https://doi.org/10.15420/icr.2023.03

2023-12-06

Abstract:Since the first robotic-assisted percutaneous coronary intervention procedure (R-PCI) was performed in 2004, there has been a steady evolution in robotic technology, combined with a growth in the number of robotic installations worldwide and operator experience. This review summarises the latest developments in R-PCI with a focus on developments in robotic technology, procedural complexity, tele-stenting and training methods, which have all contributed to the global expansion in R-PCI.
A Novel Robotic Control System Mimics Doctor’s Operation to Assist Percutaneous Coronary Intervention

Boda Zhou,Qizhong Li,Yajun Xue,Lihao Huang,Jie Zhou,Ou Zhang,Ping Zhang,Gangtie Zheng

DOI: https://doi.org/10.15212/cvia.2022.0003

2022-01-01

Cardiovascular Innovations and Applications

Abstract:Objectives: The use of current robotic systems to assist in percutaneous coronary intervention (PCI) fundamentally differs from performing conventional PCI. To overcome this problem, we developed a novel master-slave robotic control system to assist in PCI, and evaluated its safety and feasibility in the delivery and manipulation of coronary guidewires in vitro and in vivo . Methods: The novel robotic assist PCI system is composed of three parts: 1) a master actuator, which imitates the traditional torque used by surgeons in conventional PCI, 2) a slave actuator, including a guidewire delivery system and force monitoring equipment, and 3) a local area network based communication system. Results: The experiment was performed in six pigs. Both robotic and manual control completed the operation with no device- or procedure-associated complications. An experienced interventional cardiologist who was a first-time user of the novel robotic PCI system was able to advance the guidewire into a distal branch of a coronary artery within a similar time to that required with the manual procedure. Conclusion: This early in vivo experiment with the novel robotic assisted PCI control system demonstrated that its feasibility, safety, and procedural effectiveness are comparable to those of manual operation. The novel robotic-assisted PCI control system required significantly less time to learn than other currently available systems.
Mid-term Clinical Outcomes of Robotic-Assisted Reverse Hybrid Coronary Revascularization. A Single Center Experience.

Aleksander Dokollari,Marco Gemelli,Serge Sicouri,William A. Gray,Timothy A. Shapiro,Frank McGeehin,Marwan Badri,Paul Coady,Eric Gnall,Mara Caroline,Amid A. Khan,Massimo Bonacchi,Francesco Cabrucci,Beatrice Bacchi,Bruno Chiarello,Ashish Shah,Aaron Spooner,Nitin Ghorpade,Ali Fatehi Hassanabad,Stephanie Kjelstrom,Georgia Montone,Mary Ann Wertan,Basel Ramlawi,Francis P. Sutter

DOI: https://doi.org/10.1016/j.amjcard.2023.12.054

IF: 3.133

2024-01-07

The American Journal of Cardiology

Abstract:BACKGROUND Outcomes of robotic-assisted reverse hybrid coronary revascularization (HCR) remain hindered. We aim to analyze mid-term clinical outcomes of robotic-assisted reverse HCR. METHODS All consecutive 285 patients that underwent reverse robotic-assisted HCR between 09/2005-07/2021 are included. Reverse HCR consists of percutaneous coronary intervention (PCI) with stent implantation in non-left anterior descending (LAD) coronary artery vessels performed within 30-days prior to robotic-assisted left internal thoracic artery (LITA) harvesting and LITA to LAD manual anastomosis through a 4-cm left minithoracotomy. Dual antiplatelet therapy was not interrupted on any patient. RESULTS Preoperatively, mean age was 70.2 (± 11.2) years old. Prior to surgery, a total of 168 patients received 1 stent, 112 patients 2 stents, and 5 patients 3 stents. Intraoperatively, mean OR time was 5.9 (± 1) hours, no case was converted to full sternotomy, while 9 (3.1%) patients received intraoperative blood products transfusions. Postoperatively, a low incidence of stroke 1 (0.3%), reoperation for bleeding 7 (2.4%), blood product transfusions 48 (16.8%), and hospital stay (4.8 days) was observed. At 30-day follow-up, 1 (0.3%) patient underwent PCI with stent on a surgical LITA-LAD anastomosis due to graft failure. Mean follow-up was 4.2-years. Reported mid-term outcomes included all-cause death in 31 patients (10.9%), MACCE in 102/285 (35.9%), nonfatal stroke in 2/285 (0.7%), MI in 17/285 (5.9%), and repeat intervention in 50/285 (17.5%) patients. CONCLUSION This single center study reports effective and safe clinical outcomes at mid-term follow-up of reverse HCR procedures for treatment of multivessel coronary artery disease.

cardiac & cardiovascular systems
In-Vivo Validation of a Novel Robotic Platform for Endovascular Intervention

Giulio Dagnino,Dennis Kundrat,Trevor M Y Kwok,Mohamed E M K Abdelaziz,Wenqiang Chi,Anh Nguyen,Celia Riga,Guang-Zhong Yang

DOI: https://doi.org/10.1109/TBME.2022.3227734

Abstract:Objective: In-vivo validation on animal setting of a pneumatically propelled robot for endovascular intervention, to determine safety and clinical advantage of robotic cannulations compared to manual operation. Methods: Robotic assistance and image-guided intervention are increasingly used for improving endovascular procedures with enhanced navigation dexterity and accuracy. However, most platforms developed in the past decade still present inherent limitations in terms of altered clinical workflow, counterintuitive human-robot interaction, and a lack of versatility. We have created a versatile, highly integrated platform for robot-assisted endovascular intervention aimed at addressing such limitations, and here we demonstrate its clinical usability through in-vivo animal trials. A detailed in-vivo study on four porcine models conducted with our robotic platform is reported, involving cannulation and balloon angioplasty of five target arteries. Results: The trials showed a 100% success rate, and post-mortem histopathological assessment demonstrated a reduction in the incidence and severity of vessel trauma with robotic navigation versus manual manipulation. Conclusion: In-vivo experiments demonstrated that the applicability of our robotic system within the context of this study was well tolerated, with good feasibility, and low risk profile. Comparable results were observed with robotics and manual cannulation, with clinical outcome potentially in favor of robotics. Significance: This study showed that the proposed robotic platform can potentially improve the execution of endovascular procedures, paving the way for clinical translation.
Second-generation robotic angioplasty system use for the treatment of ST-elevation myocardial infarction: a first-in-man proof of concept case report

Felix J Hofmann,Oliver Dörr,Florian Blachutzik,Albrecht Elsässer,Helge Möllmann,Alessa-Janine Köhne,Holger M Nef

DOI: https://doi.org/10.1093/ehjcr/ytad089

2023-03-01

European Heart Journal - Case Reports

Abstract:Abstract Background Robotically assisted remote-controlled PCI (rPCI) was introduced in the past decade as one of the latest enhancements in this rapidly evolving field. The use of a second-generation rPCI system in ST-elevation myocardial infarction (STEMI) is an effort to couple immediate revascularization with the accuracy of newer robotic assistance and software support. Case summary Here we report on the safety and efficacy of rPCI applied to a 74-year-old female STEMI patient with persistent acute chest pain as well as regional wall motion abnormalities in the echocardiogram. The first medical contact-to-device time was 76 min, and door-to-balloon time was 33 min. The impatient course was uneventful, so the patient was discharged from hospital after 5 days. To the best of our knowledge, this is the first report of the successful application of second-generation rPCI in STEMI. Discussion In the case presented, rPCI was feasible and safe even in acute coronary syndrome based on a single-centre experience. rPCI is a revolutionary new technique that may be applied to various types of clinical presentations.
Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial

Shaoxi Niu,Liyan Ao,Yu Gao,Fangjian Zhou,Wang He,Jin Tao,Shengjie Guo,Baojun Wang,Xing Ai,Hongzhao Li,Xin Ma,Xuepei Zhang,Jian Huang,Xu Zhang

DOI: https://doi.org/10.1016/j.euros.2024.02.017

IF: 3

2024-04-26

European Urology Open Science

Abstract:Background and objective Robot-assisted radical prostatectomy (RARP) is widely used because of the many advantages of a robotic approach. The da Vinci Si robot is one of the most commonly used surgical robot systems, but it may be associated with higher costs owing to the use of consumable surgical supplies. Our aim was to conduct a preliminary investigation of the capability of the MP1000 system for RARP. Methods In this prospective, multicentre, single-blinded study, we randomly assigned 42 patients scheduled to undergo RARP between April and September 2021 to a da Vinci Si group (control) or an MP1000 group (intervention). Patients underwent RARP performed using the assigned robotic system and were followed up at 3-mo intervals. The primary outcome was the rate of conversion to open/laparoscopic surgery. Secondary outcomes were installation and operation times, intraoperative blood loss, postoperative surgical margin status, hospital stay, incontinence, complications, safety indicators, and surgeon ergonomics. Key findings and limitations All procedures were successfully completed without conversion to open/laparascopic surgery or major complications. Secondary outcomes, including oncological and ergonomic indicators, did not differ significantly between the groups over the study period. One patient in the control group experienced dysuria (Clavien-Dindo grade 3). No patients had incontinence at 3 mo. A limitation of the study is the small sample size. Conclusions and clinical implications RARP with the MP1000 system is feasible, safe, and effective in the management of localised prostate cancer. Patient summary We assessed the effectiveness and safety of the new MP1000 robot system for robot-assisted removal of the prostate in comparison to the da Vinci Si robot. We found no difference in effectiveness or safety among 42 patients with prostate cancer who were assigned randomly to one of the two systems. We conclude that the MP1000 is a suitable robot for this surgery.

urology & nephrology
Human Vs. Machine: Are Robotic Neurointerventions More Precise In A Controlled Benchtop Environment?

Guillaume Charbonnier,Arturo Consoli,Nicole Cancelliere,Eileen Liu,Jose Danilo B. Diestro,Tom Marotta,Julian Spears,Alessandra Biondi,Vitor Mendes Pereira

DOI: https://doi.org/10.1016/j.neurad.2024.01.056

IF: 4.6

2024-02-25

Journal of Neuroradiology

Abstract:Background Robotic endovascular treatment are now a reality, and future tools are being developed targeting neurointerventions. Although it is clear that the technology increases operator comfort and reduce their X-ray exposure, it is not certain that it achieves the same precision as manual cases. We compared manual and robotically assisted procedures in a virtual environment with new precision metrics to evaluate robotic technology using the Corpath GRX (Siemens, Erlangen, Germany). Methods We defined 3 tasks (easy, medium and hard) of intracranial aneurysm catheterization. We used the G5 Mentice Lab (Mentice, Göteborg, Sweden) to perform the simulated procedures. At the end of every procedure, we could collect the total translation in centimeters and of the microcatheter and the microwire. Two blinded neurointerventionists reviewed the number of re-entry into the aneurysm and catheter or wire "jump", defined as a quick, uncontrolled movement of the tool to the aneurysm wall. Results We performed 68 cases: 34 robotic cases and 34 manual cases, on 3 different aneurysms virtual simulations. We had 12 operators on the easy case and 11 operators on the medium and difficult case. In the difficult case, operators used less microwire translation using the robotic assistance than performing the task manually with a mean of 38,7 cm vs. 108,4 cm, p=0.023 (Figure 1). There was no statistical difference in the easy and medium case. More than one try to catheterize the target was seen 55% of time in the difficult case done manually vs. 9% with the robotic assistance, which almost reach the statistical significance p = 0.063. Dangerous jumps were not statistically different in either 3 cases. Procedural time was not statistically different in the 2 groups. Conclusion Robotic procedures seem to be more precise in difficult cases and is associated with less microwire manipulations than in manual cases.

radiology, nuclear medicine & medical imaging,clinical neurology,neuroimaging
An Investigation of Analytic Decision During Driving Test

S. Ghouali,Yassine Zakarya Ghouali,M. Feham

DOI: https://doi.org/10.14569/IJACSA.2017.080221

Abstract:To examine the long-term causality between Cardiorespiratory Electromyography Galvanic signals for 17 drivers taken from Stress Recognition in Automobile Drivers database. Methods: Two statistical methods, co-integration to reveal an eventual existence of a long-term relationship between ECG (Electrocardiograph), EMG (electromyography), GSR (galvanic skin resistance), heart rate (HR) and respiration, well as the Application of the model of Granger causality. Results: ECG shows certain dependence to EMG, GSR, heart rate and respiration. The results for ECG dependent suggest that an increase of 1% in EMG, FOOTGSR, HAND GSR, HR and RESPIRATION implies a variation of ECG which take a value respectively of 0.016248%, 0.007241%, 0.028366%, 0.000511% and 0.000110% in the within dimension based on the FMOLS (Fully Modified Ordinary Least Squares). With same way, the result for ECG suggest that an increase of 1% in EMG, FOOT GSR, HAND GSR, HR and RESPIRATION implies a variation of ECG which take a value respectively, of 0.065684%, 0.014534%, 0.032800%, 0.000304%, 0.005986% in the between dimension based on the same method. The results of panel Granger causality show a bi-directional relationship between ECG and FOOT GSR, HAND GSR and respiration signals, it must be noted as a unidirectional causality from EMG to ECG. Conclusion: This study shows the long-term interaction between the bio signals, and reveal how the understanding of these interactions can help the doctors to understand the risks that may exist between these interactions. The main advantage of a multidimensional and multivariate model is to solve a multitude of problems that prevent doctors to treat the patients better and is not the case for studies in two dimensions.
Combined Rotational Excimer lASER Coronary Atherectomy (RASER) in Non-crossable, Non-dilatable Coronary Artery Disease: Observations From a Single Center

Kerrick Hesse,Samay Mehta,Celine Tam,Faizan Ahmed,Farhan Shahid,Gary S Mintz,Javed M Ahmed,Gary Mintz,Javed Ahmed

DOI: https://doi.org/10.25270/jic/23.00267

2024-01-01

Journal of invasive cardiology

Abstract:BACKGROUND: Balloon non-crossable stenoses represent a challenging subset of coronary artery disease (CAD). They are clinically associated with patients who are older, frailer, and with multi-morbidities, and angiographically with increased tortuosity and coronary artery calcification. Combined rotational (RA) excimer laser coronary atherectomy (ELCA), or RASER, may facilitate stent delivery and deployment in non-crossable, non-dilatable severely calcified lesions. In this study, we assessed preliminary safety and efficacy of the RASER hybrid technique.METHODS: RASER feasible percutaneous coronary intervention (PCI) procedures performed at a large tertiary hospital in the northeast of England were retrospectively analyzed from September 1, 2008, to February 28, 2022. Major endpoints were in-hospital death from any cause, as well as procedural and angiographic success, defined by stent delivery with less than 50% residual stenosis and without clinical or angiographic complications, respectively.RESULTS: From 74 unique cases, there were 28 RASER, 24 ELCA/RA, 16 balloon angioplasty ± stenting, and 6 medically treated patients. In-hospital mortality rate was 5.2%, including 1 ELCA- and 3 RASER-treated patients. Successful stent delivery was achieved in significantly more RASER-treated patients compared to ELCA/RA- or balloon-treated patients: 96.4% (27/28), 25% (6/24), and 31.3% (5/16) respectively (P less than .001).CONCLUSIONS: In our retrospective, single-center study, patients with CAD who were deemed appropriate for RASER PCI had a high peri-procedural mortality rate. In this context, adjunctive RASER therapy provides acceptable safety and efficacy as a bailout strategy, with at least 3 out of 5 patients achieving satisfactory procedural and angiographic results. Randomized controlled trials are needed to comprehensively compare the clinical outcomes of high-risk RASER PCI vs conservative medical therapy.

cardiac & cardiovascular systems
Feasibility, safety and effectiveness of robot-assisted radical prostatectomy with a new robotic surgical system: a prospective, controlled, randomized clinical trial

Jie Dong,Ruoyu Ji,Liang Cui,Guanghua Liu,Yi Xie,Jingmin Zhou,Huizhen Wang,Weifeng Xu,Zhigang Ji

DOI: https://doi.org/10.1186/s12885-024-12855-w

IF: 4.638

2024-09-29

BMC Cancer

Abstract:Robot-assisted radical prostatectomy (RARP) gains increasing popularity in the surgical management of prostate cancer (PCa) but is challenged by its prohibitive expense. A domestic robotic system has been developed to address this issue, but data comparing the self-developed robot with the widely used robot is lacking. We performed a randomized clinical trial to compare KD-SR-01 ® and DaVinci ® robots in terms of perioperative, short-term oncological and functional outcomes in RARP.

oncology

[Individual characteristics of the brain energy metabolism during local ischemia obtained by nuclear magnetic resonance in vivo].

Abstract 11630: Comparing Outcomes Between Robotic Assisted versus Manual Percutaneous Coronary Intervention - A Meta-Analysis of 2,203 Patients

Local anaesthetic effects on trophoblast membrane fluidity.

A Systematic Review of R-PCI

Twelve-month outcome of robotic assisted PCI

Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience

Comparison of Robotic Percutaneous Coronary Intervention With Traditional Percutaneous Coronary Intervention

Multiple endokrine Neoplasie assoziiert mit multiplen Lipomen

Robotics in percutaneous cardiovascular interventions

Contribution and advances of robotics in percutaneous oncological interventional radiology

OFFPRINTED FROM Moral Particularism

Latest Developments in Robotic Percutaneous Coronary Interventions

A Novel Robotic Control System Mimics Doctor’s Operation to Assist Percutaneous Coronary Intervention

Mid-term Clinical Outcomes of Robotic-Assisted Reverse Hybrid Coronary Revascularization. A Single Center Experience.

In-Vivo Validation of a Novel Robotic Platform for Endovascular Intervention

Second-generation robotic angioplasty system use for the treatment of ST-elevation myocardial infarction: a first-in-man proof of concept case report

Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial

Human Vs. Machine: Are Robotic Neurointerventions More Precise In A Controlled Benchtop Environment?

An Investigation of Analytic Decision During Driving Test

Combined Rotational Excimer lASER Coronary Atherectomy (RASER) in Non-crossable, Non-dilatable Coronary Artery Disease: Observations From a Single Center

Feasibility, safety and effectiveness of robot-assisted radical prostatectomy with a new robotic surgical system: a prospective, controlled, randomized clinical trial